Article info
Colon
Original research
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
- Correspondence to Dr Eduardo Vilar, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; evilar{at}mdanderson.org
Citation
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
Publication history
- Received February 20, 2020
- Revised June 5, 2020
- Accepted June 6, 2020
- First published July 8, 2020.
Online issue publication
February 05, 2021
Article Versions
- Previous version (8 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.